Trinity Biotech | TRIB - Capital Ordinaire





Capital Ordinaire Changement Date
Abbott USD 1.74B 2.94M 2026-03
Bayer EUR 982.42M 0 2026-09
Bio-Rad Laboratories USD 26.74M 91K 2026-06
EDAP TMS EUR 37.48M 90K 2026-03
J&J USD 2.41B 1.64M 2026-06
Mesa Laboratories USD 349.53M 3.53M 2024-09
OraSure Technologies USD 70.39M 1.87M 2025-12
Plus Therapeutics USD 275K 138.4M 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Siemens EUR 762.74M 0 2026-06
Thermo Fisher Scientific USD 369.75M 1.88M 2026-09
Tosoh JPY 307.99M 103K 2026-09
Trinity Biotech USD 386.76M 0 2026-03
Veracyte USD 80.39M 598K 2026-09